We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
Live webcast fireside chat on Tuesday, May 21st at 2:40 PM ET LA JOLLA, CA, May 14, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company...
Interim data readout of Phase 2a biomarker study evaluating lead program GRI-0621 for the treatment of Idiopathic Pulmonary Fibrosis (IPF) expected Q3 2024 and topline data on track for Q4 2024...
LA JOLLA, CA, April 29, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (NKT) cell...
Live webcast on Wednesday, May 1st at 3:00 PM ET LA JOLLA, CA, April 25, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an...
Ongoing efforts to build a robust global patent estate for a growing pipeline targeting high-value indications in need of innovation Continued advancement of an innovative pipeline of NKT cell...
LA JOLLA, CA, April 08, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (NKT) cell...
Ongoing Phase 2a biomarker study evaluating lead program GRI-0621 for the treatment of Idiopathic Pulmonary Fibrosis (IPF) with interim data expected H1 2024 and topline data expected H2 2024...
Live webcast on Wednesday, April 3rd at 10:10 AM ET LA JOLLA, CA, March 28, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.01 | 2.43902439024 | 0.41 | 0.4519 | 0.392 | 125844 | 0.40639201 | CS |
| 4 | -0.1076 | -20.3942380591 | 0.5276 | 0.59 | 0.375 | 131775 | 0.44050886 | CS |
| 12 | -0.3658 | -46.5512853143 | 0.7858 | 0.947 | 0.375 | 170715 | 0.67389784 | CS |
| 26 | -7.35 | -94.5945945946 | 7.77 | 8.1788 | 0.375 | 603164 | 2.40209222 | CS |
| 52 | -40.95 | -98.9847715736 | 41.37 | 49.28 | 0.375 | 341168 | 3.65052374 | CS |
| 156 | -91.98 | -99.5454545455 | 92.4 | 93.31 | 0.375 | 323350 | 4.21282477 | CS |
| 260 | -91.98 | -99.5454545455 | 92.4 | 93.31 | 0.375 | 323350 | 4.21282477 | CS |
Monksdream
3 months ago
littleharoldeh
3 months ago
tw0122
3 months ago
Monksdream
3 months ago
Monksdream
3 months ago
Invest-in-America
4 months ago
Awl416
4 months ago
IVANj
4 months ago
TheFinalCD
4 months ago
Renee
4 months ago
KOGT
7 months ago
Monksdream
8 months ago
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
